The award is for development of Nafithromycin, which is the first ever multi-drug resistant pathogen active respiratory antibiotic for the treatment of Community-Acquired Bacterial Pneumonia
Total investment incurred for setting up the new R&D Rs 250 crore
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
The USFDA inspection focused on evaluating the facility's adherence to global regulatory requirements and best practices
MedTech Mitra initiative aims to empower MedTech innovators and advance healthcare solutions
TTP Group is a leading engineering firm specializing in biotech and pharmaceutical industry
He will lead the final stages of work to commission the 54,000-square-foot facility and then lead ongoing operations at the site
eGenesis is pioneering a genome engineering-based approach in the development of safe and effective transplantable organs to end the global organ shortage
Finerenone is the first mineralocorticoid receptor (MR) antagonist to demonstrate definitive cardiovascular benefits in a Phase III study in patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of ?40%
The approval further adds to Biocon’s portfolio of complex drug products
Subscribe To Our Newsletter & Stay Updated
